Adding pharmacists to docs' offices helps patient outcomes, study shows

November 15, 2010

Adding pharmacists to the primary care team right in doctors' offices may help patients with chronic diseases such as diabetes better manage associated risks, a new University of Alberta study had found.

The blood pressure of patients with Type 2 diabetes dropped significantly when pharmacists were included in the on-site clinical examination and consulting process, the U of A study showed. Among 153 patients whose hypertension was inadequately controlled at the beginning of the study, the 82 who had advice from a pharmacist were more likely to reach blood pressure treatment targets recommended by the Canadian Diabetes Association.

As well, the study showed that with input from pharmacists, the predicted 10-year risk of cardiovascular disease for patients with Type 2 diabetes will drop by three per cent.

The results were reported online by Diabetes Care, and are scheduled to appear in the January 2011 issue of the journal. The study can currently be found online at http://diabetes.org/diabetescare.

"Pharmacists can play a more active role in primary care and community clinics," said Scot Simpson, lead author of the study. "We've already been actively collaborating on health care teams for years in hospitals."

Placing pharmacists in the doctor's office instead of in a more traditional role at the neighbourhood pharmacy allows for a more collaborative frontline approach to medication management in primary care, Simpson said.

"The doctors, nurses and pharmacists can directly discuss issues specific to any one patient, and by doing so, have the best outcome for the patient."

High blood pressure and other cardiovascular risk factors are common in people with diabetes, so effective management of medications is key to helping reduce the risk of heart attacks and stroke, Simpson added.
-end-
For more information on the study contact:
Scot Simpson, associate professor
Faculty of Pharmacy and Pharmaceutical Sciences
University of Alberta
780-492-7538
ssimpson@pharmacy.ualberta.ca

University of Alberta

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.